Asahi Kasei Acquires German Biopharma Company Aicuris

Asahi Kasei signed an agreement to acquire German biopharma firm Aicuris for approximately €780 million, expanding its infectious disease platform with completion expected in Q2 2026. The transaction is projected to boost operating profits starting from fiscal year 2028.